Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Differences and similarities between cancer and somatic stem cells: therapeutic implications

    Over the last decades, the cancer survival rate has increased due to personalized therapies, the discovery of targeted therapeutics and novel biological agents, and the application of palliative treatments. De...

    Fiorella Rossi, Hunter Noren, Richard Jove in Stem Cell Research & Therapy (2020)

  2. No Access

    Reference Work Entry In depth

    Signal Transducers and Activators of Transcription in Oncogenesis

    Ralf Buettner, Roy Garcia, Richard Jove in Encyclopedia of Cancer (2017)

  3. No Access

    Chapter

    Historical Development of STAT3 Inhibitors and Early Results in Clinical Trials

    Since the initial reports of constitutive STAT3 activation in cells transformed by viral oncoproteins, the critical role of STAT3 signaling in human cancers has been firmly established. Detailed understanding ...

    Chao-Lan Yu, Richard Jove, James Turkson in STAT Inhibitors in Cancer (2016)

  4. Article

    Open Access

    Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer

    The EGFR signaling pathway is frequently activated in human ovarian cancer and associated with poor prognosis. However, inhibition of EGFR signaling in patients with recurrent ovarian cancer has been disappoin...

    Wei Wen, Jun Wu, Lucy Liu, Yan Tian, Ralf Buettner, Meng-Yin Hsieh in Molecular Cancer (2015)

  5. No Access

    Living Reference Work Entry In depth

    Signal Transducers and Activators of Transcription in Oncogenesis

    Ralf Buettner, Roy Garcia, Richard Jove in Encyclopedia of Cancer

  6. No Access

    Article

    Revisiting STAT3 signalling in cancer: new and unexpected biological functions

  7. The Janus kinases (JAKs) are major activators of signal transducer and activator of transcription (STAT) proteins. JAK–STAT3 signalling is crucial for cancer d...

  8. Hua Yu, Heehyoung Lee, Andreas Herrmann, Ralf Buettner in Nature Reviews Cancer (2014)

  9. No Access

    Reference Work Entry In depth

    Signal Transducers and Activators of Transcription in Oncogenesis

    Ralf Buettner, Richard Jove, Roy Garcia in Encyclopedia of Cancer (2011)

  10. No Access

    Article

    STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors

    Physiological Stat3 signaling is temporally restricted. In cancer, Stat3 activity is often persistently elevated and fosters progression through its effects on tumor cells and their microenvironment. This repo...

    Heehyoung Lee, Jiehui Deng, Maciej Kujawski, Chunmei Yang, Yong Liu in Nature Medicine (2010)

  11. No Access

    Article

    STATs in cancer inflammation and immunity: a leading role for STAT3

  12. Signal transducer and activator of transcription (STAT) proteins have dual roles: they transduce signals through the cytoplasm and function as transcription fa...

  13. Hua Yu, Drew Pardoll, Richard Jove in Nature Reviews Cancer (2009)

  14. No Access

    Article

    In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses

    Tumors generate microenvironments that actively suppress the body's anti-tumor immune response. Kortylewski et al. restore immunity by delivering an siRNA against Stat3, a regulator of immune suppression, to myel...

    Marcin Kortylewski, Piotr Swiderski, Andreas Herrmann, Lin Wang in Nature Biotechnology (2009)

  15. No Access

    Reference Work Entry In depth

    Signal Transducers and Activators of Transcription in Oncogenesis

    Ralf Buettner, Roy Garcia, Richard Jove in Encyclopedia of Cancer (2009)

  16. No Access

    Article

    Signal Transduction Proteins in Tumors From Puerto Rican and Caucasian Gastric Adenocarcinoma Patients: Expression Differences With Potential for Specific Targeted Therapies

    Overexpression of the HER2/NEU gene is associated with aggressive behavior and poor prognosis in breast cancer, making the Her2/neu protein a directed-therapy target. Tumors of two Puerto Rican (PR) patients over...

    José Cangiano, Barbara A. Centeno in Digestive Diseases and Sciences (2008)

  17. No Access

    Article

    Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

    The immune system can act as an extrinsic suppressor of tumors. Therefore, tumor progression depends in part on mechanisms that downmodulate intrinsic immune surveillance. Identifying these inhibitory pathways...

    Marcin Kortylewski, Maciej Kujawski, Tianhong Wang, Sheng Wei in Nature Medicine (2005)

  18. No Access

    Article

    Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

    Vascular endothelial growth factor (VEGF) upregulation is induced by many receptor and intracellular oncogenic proteins commonly activated in cancer, rendering molecular targeting of VEGF expression a complex ...

    Qing Xu, Jon Briggs, Sungman Park, Guilian Niu, Marcin Kortylewski in Oncogene (2005)

  19. No Access

    Article

    Targeting STAT3 affects melanoma on multiple fronts

    As a point of convergence for numerous oncogenic signaling pathways, STAT3 is constitutively-activated at 50 to 90% frequency in diverse human cancers, including melanoma. A critical role of STAT3 in tumor cel...

    Marcin Kortylewski, Richard Jove, Hua Yu in Cancer and Metastasis Reviews (2005)

  20. No Access

    Article

    Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer

    Members of the signal transducers and activators of transcription (STAT) pathway have recently been demonstrated to have a major role in cancer. Constitutive activation of the STAT family members Stat3 and Sta...

    Eric B Haura, James Turkson, Richard Jove in Nature Clinical Practice Oncology (2005)

  21. No Access

    Article

    Stat3 regulates genes common to both wound healing and cancer

    Wound healing and cancer are both characterized by cell proliferation, remodeling of extracellular matrix, cell invasion and migration, new blood vessel formation, and modulation of blood coagulation. The mech...

    Daniel J Dauer, Bernadette Ferraro, Lanxi Song, Bin Yu, Linda Mora in Oncogene (2005)

  22. No Access

    Article

    Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity

    Constitutive activation of the JAK/STAT3 pathway is a major contributor to oncogenesis. In the present study, structure–activity relationship (SAR) studies with five cucurbitacin (Cuc) analogs, A, B, E, I, and...

    Jiazhi Sun, Michelle A Blaskovich, Richard Jove, Sandra K Livingston in Oncogene (2005)

  23. No Access

    Article

    Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells

    Stat3 (signal transducer and activator of transcription-3) activity is required for transformation by a number of oncogenes, while a constitutively active form of Stat3 alone is sufficient to induce neoplastic...

    Adina Vultur, Jun Cao, Rozanne Arulanandam, James Turkson, Richard Jove in Oncogene (2004)

  24. Article

    Correction: Corrigendum: Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

    Nat. Med. 10, 48–54 (2004) In Figure 3c, the x-axis label for the second bar from the left was incorrect. The label should read, “Stat-3β”. In Figure 4e (top), the y-axis label was incorrect. The label should ...

    Tianhong Wang, Guilian Niu, Marcin Kortylewski, Lyudmila Burdelya in Nature Medicine (2004)

previous disabled Page of 3